Explore life science companies operating throughout South East England, including biotechnology firms, CROs and research organisations.
Custom modified oligonucleotides for research and therapeutics
ATDBio is a University of Southampton spin-out specialising in custom DNA and RNA oligonucleotide synthesis for research, diagnostics and therapeutic development. Its Southampton-based operations supply standard and chemically modified oligos, including antisense sequences, siRNA, aptamers and labelled probes, using…
Clinical-stage company developing radioligand cancer therapies
Blue Earth Therapeutics is a clinical-stage biotechnology company developing targeted radiopharmaceutical therapies for cancer. Its pipeline centres on prostate-specific membrane antigen-targeted radioligand therapies using both beta- and alpha-emitting radionuclides, designed to deliver high radiation doses to tumour…
Antibody therapies targeting severe autoimmune diseases
argenx UK Ltd is the UK commercial subsidiary of argenx SE, a global immunology company developing antibody-based therapies for severe autoimmune diseases. The company markets VYVGART (efgartigimod), the first approved FcRn blocker in the UK, indicated for generalised myasthenia gravis and chronic inflammatory…
Peptide immunotherapies for the treatment of food allergy
Aravax is a clinical-stage biotechnology company developing next-generation specific immunotherapies for food allergy. Its lead candidate, PVX108, is a synthetic peptide-based therapy designed to desensitise peanut-allergic patients by targeting the T cells that drive allergic responses, without triggering acute…
API development and manufacturing for pharmaceutical drug substances
Aptuit is a pharmaceutical chemical development and manufacturing site operating as part of Evotec's API and drug product network. The company develops and manufactures active pharmaceutical ingredients for small molecule drugs, offering route scouting, process development and scale-up, polymorph screening, analytical…
Global biopharmaceutical company developing therapies for serious diseases
AbbVie is a global research-based biopharmaceutical company focused on the discovery, development and commercialisation of medicines across immunology, oncology, neuroscience and aesthetics. Its portfolio includes treatments for autoimmune diseases, haematological cancers, neurological conditions and women's health.…
Diagnostics, devices and diabetes care for global healthcare
Abbott Laboratories is a multinational healthcare company providing diagnostic instruments, reagents, and medical devices to hospitals, laboratories, and healthcare professionals. UK operations span commercial, R&D, and manufacturing functions across multiple sites. Core life science offerings include in vitro…
Microplate reader instrumentation for life science research and screening
BMG LABTECH is a developer and manufacturer of microplate reader instrumentation for pharmaceutical, biotechnology, and academic research applications. The company's portfolio covers a broad range of optical detection technologies including fluorescence intensity, time-resolved fluorescence, luminescence, absorbance,…
Antibody discovery biotech targeting GPCRs in inflammatory disease
DJS Antibodies is a biotechnology company developing monoclonal antibody therapeutics against G protein-coupled receptors and other previously intractable disease targets. Its proprietary antibody discovery platform enables the generation of first-in-class antibodies against transmembrane proteins that have…
AI-powered medical imaging software for stroke, oncology and lung disease
Brainomix is a UK software company specialising in AI-powered imaging biomarkers and Software as a Medical Device (SaMD) to support clinical decision-making in stroke, lung fibrosis, and cancer. Its platform provides clinicians with automated imaging analysis to guide treatment decisions in acute stroke care and is…
Immunological reagents, assay services and target-binding proteins for immune research
ProImmune is a provider of immunological reagents and assay services supporting research into adaptive immune responses. The company offers assay services to help researchers understand immune responses to vaccines and therapeutics, using ELISpot and flow cytometry techniques, alongside recombinant target-binding…
Preclinical neuroscience CRO for translational drug development research
Transpharmation is a preclinical neuroscience contract research organisation providing translational pharmacology services to pharmaceutical and biotechnology companies. The company's therapeutic expertise spans EEG, cognition, epilepsy, pain, neurodegeneration and mood disorders including treatment-resistant…
Synthetic T cell-priming vaccines and immunotherapies for infectious disease
Gylden Pharma is a clinical-stage biotechnology company developing 100% synthetic T cell-priming vaccines and immunotherapies. Its nanoparticle platform delivers synthetic peptides that stimulate cellular immune responses against intracellular pathogens, providing strain-agnostic protection without cold-chain…
High-capacity viral vector manufacturing platform for gene therapy
Icosphere Biosciences is a biotechnology company developing manufacturing technology for high-capacity gene therapy vectors. Its platform enables scalable, high-yield, contamination-free production of high capacity adenoviral vectors capable of carrying substantially more genetic material than conventional viral…
Intra-uterine sensor platform for continuous uterine biomarker monitoring
Verso Biosense is a femtech medtech company developing a miniaturised intra-uterine sensor device for continuous physiological monitoring of the uterus. The battery-free implantable device measures temperature, dissolved oxygen, and pH in real time, transmitting data wirelessly to a proprietary software platform.…
AI-powered rapid pathogen ID and antibiotic susceptibility from blood
Vivid Dx is a University of Oxford spin-out developing a culture-free diagnostics platform for rapid pathogen identification and antimicrobial susceptibility testing directly from blood samples. The system combines Raman spectroscopy, microfluidics, and deep learning to deliver species-level pathogen identification in…
AI-powered digital pathology laboratory services for rapid cancer diagnosis
Inify Laboratories is a digital pathology company providing cancer diagnostic services through a fully digital, AI-supported laboratory workflow. The company processes tissue biopsy samples, generating whole slide images that are analysed by its proprietary AI software before review and reporting by specialist…
The UK's largest single-ownership science and technology park near Oxford
Milton Park is the UK's largest single-ownership science, business and technology park, located in South Oxfordshire between Abingdon and Didcot. Spanning 300 acres with nearly three million square feet of floor space, it hosts over 270 organisations across life sciences, energy, space and supporting technologies, and…
Injectable biomaterial gel to treat degenerative disc disease
Orthoson is a medtech company developing micro-invasive injectable treatments for chronic back pain caused by degenerative disc disease. Its lead product, a patented pNIPAM-DMAc co-polymer hydrogel, is designed to be injected into the intervertebral disc, where it gels in-situ to restore the mechanical and biological…
Oncolytic virus immunotherapies engineered to destroy solid tumours
Bioarchitech is a preclinical-stage biotechnology company developing oncolytic virus-based immunotherapies for the treatment of common solid tumours. The company engineers vaccinia virus to encode antibody-like immunotherapy molecules within the viral genome, enabling localised delivery of immune-activating payloads…